Techne Corp. 614 McKinley Place NE Minneapolis,
MN 55413-2610 United States - Map Phone: 612-379-8854 Fax: 612-379-6580 Website: http://www.techne-corp.com
TECHNE Corporation develops, manufactures, and sells biotechnology research and diagnostic products, and hematology calibrators and controls worldwide. The companys Biotechnology segment offers proteins, such as cytokines, and enzyme substrates and inhibitors; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising quantikine kits for the detection of human and animal proteins, and immunoassays that allow researchers to quantify a specific analyte in a biological fluids sample; clinical diagnostic immunoassay kits consisting of erythropoietin, transferrin receptor, and beta2-microglobulin immunoassays for use as in vitro diagnostic devices; flow cytometry products, such as fluorochrome labeled antibodies and kits; intracellular cell signaling products, including antibodies, phospho-specific antibodies, antibody arrays, active caspases, kinases, phosphatases, and enzyme-linked immunosorbant assays to measure the activity of apoptotic and signaling molecules; and natural and synthetic chemical compounds for use as agonists, antagonists, and inhibitors of various biological functions by investigators. Its Hematology segment provides a range of hematology controls and calibrators for impedance and laser type cell counters; and hematology control products for use as proficiency testing tools by laboratory certifying authorities. The company was founded in 1976 and is headquartered in Minneapolis, Minnesota. Key Statistics
| |
| Techne Corp.’s ISS Governance QuickScore as of May 1, 2013 is 3. The pillar scores are Audit: 1; Board: 8; Shareholder Rights: 1; Compensation: 5. | | Brought to you by Institutional Shareholder Services (ISS) |
| | Pay | Exercised | Dr. Roger C. Lucas Ph.D.,
70 Vice Chairman, Sr. Scientific Advisor, Member of Nominations & Governance Committee and Member of Scientific Subcommittee | 25.00K | N/A | Mr. Gregory J. Melsen ,
61 Chief Financial Officer, VP of Fin. and Treasurer | 342.00K | 0.00 | Mr. Marcel Veronneau ,
59 VP of Hematology Operations | 219.00K | 0.00 | Mr. Charles R. Kummeth ,
53 Chief Exec. Officer and Director | N/A | N/A | Kathleen M. Backes ,
Chief Accounting Officer and Controller | N/A | N/A |
|
| | Amounts are as of Dec 30, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year. | | Currency in USD. |
|